ANZMIG

Australia and New Zealand Mycoses Interest Group

ANZMIG promotes excellence in clinical and laboratory mycology through collaborative clinical and translational research focussed on improving patient-centred outcomes.

  • ANZMIG aims to:

    Foster and advance education and training in the pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prevention of fungal infections.

    Develop national guidelines for management of mycological infections.

    Facilitate and promote investigator-initiated, collaborative clinical and applied mycological research throughout Australia and New Zealand.

    Contribute to program development of other ad hoc educational meetings involving Mycology.

    ANZMIG educational activities include:

    Organising the Mycology Masterclass Program every two years

    Inviting Advanced Trainees in Infectious Diseases/Microbiology to present their work at three ANZMIG meetings each year.

    An ANZMIG Symposia at the ASID Annual Scientific Meeting.

    ANZMIG awards a seed grant to an ASID member valued at $30,000 per annum to support research towards a PhD degree.

    Inviting scientists and other clinicians to present.

    Committee:

    Co-Chairs: Dr Celia Cooper and Dr Caitlin Keighley
    Immediate past Co-Chair: Assoc Prof Karina Kennedy
    Secretary: Dr Sarah Kidd
    Scientific Chair: Dr Lucy Crawford
    Working Group Chairs: Prof Monica Slavin and Assoc Prof Sharon Chen
    Trainee Representative: Dr Max Kernich
    Clinical Lead: Dr Abby Douglas
    Laboratory Lead: Dr Catriona Halliday

    Terms of Reference

  • Access ANZMIG videos anytime.

  • Study Proposal Applications received will be reviewed in line with the ANZMIG Endorsement Process.

  • Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand.
    Clinical Infectious Diseases. 26 May 2023.

    Australasian Consensus Guidelines for the use of antifungal agents in the haematology‐oncology setting. 2021 update. IMJ. November 2021.

    Diagnosis, management and prevention of Candida auris in hospitals. Ong CW, Chen SC, Clark JE, Halliday CL, Kidd SE, Marriott DJ, Marshall CL, Morris AJ, Morrissey CO, Roy R, Slavin MA, Stewardson AJ, Worth LJ, Heath CH; Australian and New Zealand Mycoses Interest Group (ANZMIG); and the Healthcare Infection Control Special Interest Group (HICSIG). Intern Med J. 2019 Oct;49(10):1229-1243. doi: 10.1111/imj.14612.

    ANZMIG Publications 2005-2017: See list.